| (USD) | Jan 2024 | Q/Q |
|---|---|---|
| Revenue | 1.6B | -2% |
| Gross Profit | 351MM | +4% |
| Cost Of Revenue | 1.3B | -4% |
| Operating Income | 70MM | +23% |
| Operating Expenses | 281MM | -0% |
| Net Income | 47.7MM | +19% |
| Interest Expense | 11.7MM | +10% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and services. It’s one of the essentials of life, which makes the industry such a politically sensitive matter. Besides the critical need, another element that helps bolster the case for healthcare stocks is the underlying diversity. Yes, the sector centers on the pharmaceutical innovation space. However,
With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem. As a Reuters report mentioned recently, publicly traded technology enterprises witnessed a huge outflow of $4.4 billion. In fact, it was the largest-ever outflow of funds over a single week. It’s not hard to understand why. As artificial intelligence and other technologies boosted share prices, it makes sen
Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.
The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share...
ST. PAUL, Minn., March 12, 2024--On March 11, 2024, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) approved a new share repurchase authorization for the repurchase of up to $500 million of the company’s common stock through March 16, 2027, replacing a prior authorization which was expiring and under which there was $194.9 million remaining.
ST. PAUL, Minn., March 02, 2024--Patterson Dental has an alternative solution to restore insurance claims processing for Eaglesoft customers. The recent cyber incident impacting Change Healthcare resulted in many dental practices being unable to process insurance claims, which has had a tremendous impact on customers.
Last week, you might have seen that Patterson Companies, Inc. ( NASDAQ:PDCO ) released its third-quarter result to the...
Patterson Companies, Inc. (NASDAQ:PDCO) Q3 2024 Earnings Call Transcript February 28, 2024 Patterson Companies, Inc. misses on earnings expectations. Reported EPS is $0.516 EPS, expectations were $0.6. PDCO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome […]
Patterson Companies' (PDCO) third-quarter fiscal 2024 results reflect an improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales appear weak.
ST. PAUL, Minn., February 28, 2024--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2024 third quarter ended January 27, 2024.